Related references
Note: Only part of the references are listed.Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Victor M. Corman et al.
EUROSURVEILLANCE (2020)
Redefining non-alcoholic fatty liver disease: what's in a name?
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Complications, morbidity and mortality of nonalcoholic fatty liver disease
Alessandro Mantovani et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Sadaf G. Sepanlou et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores
Giovanni Targher et al.
GUT (2020)
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
Safiya Richardson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico
Omar Yaxmehen Bello-Chavolla et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study
Dong Ji et al.
JOURNAL OF HEPATOLOGY (2020)
Impacts of immunosuppression and immunodeficiency on COVID-19: A systematic review and meta-analysis
Ya Gao et al.
JOURNAL OF INFECTION (2020)
Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis
Wenjie Tian et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Liver injury in COVID-19: The current evidence
Saleh A. Alqahtani et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2020)
Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
Abdulzahra Hussain et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Chronic inflammation in the etiology of disease across the life span
David Furman et al.
NATURE MEDICINE (2019)
Spectrum of respiratory viral infections in liver disease patients with cirrhosis admitted in critical care unit
Vijeta Bajpai et al.
JOURNAL OF LABORATORY PHYSICIANS (2019)
Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis
Jonel Trebicka et al.
FRONTIERS IN IMMUNOLOGY (2019)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States
Michael H. Le et al.
PLOS ONE (2017)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo et al.
GASTROENTEROLOGY (2015)
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
Paul Angulo et al.
HEPATOLOGY (2007)
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
JD Browning et al.
HEPATOLOGY (2004)
Noninvasive evaluation of graft steatosis in living donor liver transplantation
M Iwasaki et al.
TRANSPLANTATION (2004)
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
CT Wai et al.
HEPATOLOGY (2003)
Share Paper
